This finding is consistent with that of a previous study indicating that high‐grade gliomas, which are more hypoxic, show increased CMRO2 and neovascularization, whereas IDH mutations in low‐grade gliomas are associated with decreased CMRO2 [36]. This evidence concerns the gene IDH1 and central nervous system cancer.